Treatment-resistant recurrent unipolar and bipolar depression: associative learning abnormalities.

Area of Science:

• Neuroscience
• Psychiatry
• Cognitive Science

Background:

• Severe and enduring psychiatric illness impacts 3% of the UK population, causing disability and reduced life expectancy.
• Treatment-resistant recurrent unipolar depression and bipolar depression are distinct conditions requiring different treatments.
• Clinical presentation of bipolar depression can mimic unipolar depression, necessitating objective diagnostic methods.

Purpose of the Study:

• To investigate neural abnormalities in treatment-resistant unipolar and bipolar depression using neuroimaging and computational modeling.
• To test the hypothesis of similar blunted reward learning and increased loss avoidance signals in both depression types.
• To identify objective markers for discriminating between unipolar and bipolar depression.

Main Methods:

• Employed reinforcement learning drift diffusion models of decision-making.
• Utilized event-related functional magnetic resonance imaging (fMRI) during a reward and loss avoidance task.
• Analyzed data from patients with treatment-resistant recurrent unipolar depression and bipolar depression.

Main Results:

• Both depression types exhibited slowed decision-making, with model parameters correlating with depression severity.
• Unipolar depression showed blunted positive feedback signals and heightened negative feedback signals.
• Bipolar depression displayed preserved striatal reward prediction error signaling and lacked enhanced hippocampal/lateral orbitofrontal encoding of loss events seen in unipolar depression. A support vector machine differentiated the types with 74.3% accuracy.

Conclusions:

• While both conditions share some neural abnormalities (lateral orbitofrontal cortex, amygdala), significant differences exist in hippocampal, striatal, and lateral orbitofrontal function.
• These distinct neural patterns offer potential for objective discrimination between treatment-resistant unipolar and bipolar depression.
• Further research on currently ill patients with severe and enduring illness is warranted.